CRSP
Price
$33.14
Change
-$0.89 (-2.62%)
Updated
Apr 1 closing price
Capitalization
2.92B
40 days until earnings call
RXRX
Price
$5.09
Change
-$0.20 (-3.78%)
Updated
Apr 1 closing price
Capitalization
2.05B
35 days until earnings call
Ad is loading...

CRSP vs RXRX

Header iconCRSP vs RXRX Comparison
Open Charts CRSP vs RXRXBanner chart's image
CRISPR Therapeutics AG
Price$33.14
Change-$0.89 (-2.62%)
Volume$2.18M
Capitalization2.92B
Recursion Pharmaceuticals
Price$5.09
Change-$0.20 (-3.78%)
Volume$16.98M
Capitalization2.05B
CRSP vs RXRX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. RXRX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Buy and RXRX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CRSP: $34.03 vs. RXRX: $5.29)
Brand notoriety: CRSP and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 184% vs. RXRX: 71%
Market capitalization -- CRSP: $2.92B vs. RXRX: $2.05B
CRSP [@Biotechnology] is valued at $2.92B. RXRX’s [@Biotechnology] market capitalization is $2.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CRSP and RXRX are a bad buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а -20.15% price change this week, while RXRX (@Biotechnology) price change was -22.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($2.92B) has a higher market cap than RXRX($2.05B). CRSP YTD gains are higher at: -13.542 vs. RXRX (-21.746). RXRX (-426.72M) and CRSP (-447.31M) have comparable annual earnings (EBITDA) . CRSP has more cash in the bank: 1.9B vs. RXRX (594M). RXRX has less debt than CRSP: RXRX (108M) vs CRSP (224M). RXRX has higher revenues than CRSP: RXRX (58.5M) vs CRSP (35M).
CRSPRXRXCRSP / RXRX
Capitalization2.92B2.05B143%
EBITDA-447.31M-426.72M105%
Gain YTD-13.542-21.74662%
P/E RatioN/AN/A-
Revenue35M58.5M60%
Total Cash1.9B594M321%
Total Debt224M108M207%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CUSEX33.020.17
+0.52%
Capital Group US Equity
GCTIX44.37N/A
N/A
Goldman Sachs US Tax-Managed Eq Instl
DBMAX24.80N/A
N/A
BNY Mellon Sm/Md Cp Gr A
CNWCX74.76-0.50
-0.66%
American Funds New World 529C
BTLSX7.73-0.16
-2.03%
Baillie Gifford Intl Concntr Gr EqsInstl